# Recommendations for the Management of Donor and Units that are Initially Reactive for Hepatitis B Surface Antigen (HBsAg) - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/memorandum/recommendations-for-the-management-of-donor-and-units-that-are-initially-reactive-for-hepatitis-b-surface-antigen-hbsag/0783c417-4bec-4063-bda4-98590b89d010

> FDA guidance document: Recommendations for the Management of Donor and Units that are Initially Reactive for Hepatitis B Surface Antigen (HBsAg). Issue date: December 02, 1987. Get complete insights and analysis.

---

## Details

- Title: Recommendations for the Management of Donor and Units that are Initially Reactive for Hepatitis B Surface Antigen (HBsAg)
- Communication Type: Memorandum
- Product Type: biologics
- Office Name: Center for Biologics Evaluation and Research
- Office URL: /offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
- Issue Date: 1987-12-02
- Last Changed: 2020-07-16
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2013-S-0613">FDA-2013-S-0613</a>

## Related Documents

- [Recommendations for the Quarantine and Disposition of Units from Prior Collections from Donors with Repeatedly Reactive Screening Tests for Hepatitis B Virus (HBV), Hepatitis C Virus (HCV) and Human T-Lymphotropic Virus Type I (HTLV-I)](https://www.globalkeysolutions.net/guidances/memorandum/recommendations-for-the-quarantine-and-disposition-of-units-from-prior-collections-from-donors-with-repeatedly-reactive-screening-tests-for-hepatitis-b-virus-hbv-hepatitis-c-virus-hcv-and-human-t-lymphotropic-virus-type-i-htlv-i/0dfc95d9-9a1a-4ce9-aca0-109d948f753c)
- [Revised Recommendations for Testing Whole Blood, Blood Components, Source Plasma and Source Leukocytes for Antibody to Hepatitis C Virus Encoded Antigen (Anti-HCV)](https://www.globalkeysolutions.net/guidances/memorandum/revised-recommendations-for-testing-whole-blood-blood-components-source-plasma-and-source-leukocytes-for-antibody-to-hepatitis-c-virus-encoded-antigen-anti-hcv/42a2606c-55c7-41fb-bfc7-fc548bbc8704)
- [Donor Deferral Due to Red Blood Cell Loss During Collection of Source Plasma by Automated Plasmapheresis](https://www.globalkeysolutions.net/guidances/memorandum/donor-deferral-due-to-red-blood-cell-loss-during-collection-of-source-plasma-by-automated-plasmapheresis/5e298c66-6f31-48eb-ac26-66adf2b26fe6)